The IMATHERA team welcomes three new PhD students

👉 At the start of 2026, the IMATHERA preclinical imaging research team at the @CGFL – Centre Georges-François Leclerc (Department of Nuclear Medicine) in Dijon is delighted to welcome three new PhD students:

🔹 @Annaëlle Moreau: Theranostic strategies for pulmonary fibrosis: development of treatment vectorization strategies targeting GRP94 and imaging tools for treatment response (PhD supervised by Dr. @Pierre-Simon Bellaye and co-supervised by Dr. @Alexandre Dias)

🔹 @Marie Gerouville: Radiotheranostic gold nanoparticles for pancreatic cancer: modulation of innate tumor immunity and targeting of the fibroblastic stroma (PhD supervised by Prof. @Bertrand Collin, co-supervised by Dr. @Alexandre Dias and Dr. @Alan Courteau)

🔹 @John Simonet: Study of macrophage polarization (in vitro/in vivo) induced by iron nanoparticles and characterization of tumor-associated macrophages (ex vivo) in the context of solid tumors (PhD supervised by Prof. @Bertrand Collin and Dr. @Alexandre Dias and co-supervised by Dr. @Alan Courteau)

🔬 These PhD will be carried out with the support of the @CTM – Centre de recherche Translationnelle en Médecine moléculaire (CTM, UMR INSERM U1231) and the @ICMUB – Institut de Chimie Moléculaire de l’Université Bourgogne Europe RITM (ICMUB, UMR CNRS 6302).

🇪🇺 These students will strengthen the IMATHERA team working on the @i-NanoT project (innovation in Theranostic Nanovectors) supported by the @Région Bourgogne-Franche-Comté and the European Commission @L’Union Européenne (UE) as part of the FEDER-FSE+ Bourgogne-Franche-Comté and Massif du Jura 2021-2027 program.

🔗 For more information, please visit the following links :

• i-NanoT website: https://i-nanot.fr/